Elie A. Akl

Research interests

Publications

• A tool to assess risk of bias in non-randomized follow-up studies of exposure effects (ROBINS-E)

  Environment International · 2024 · https://doi.org/10.1016/j.envint.2024.108602

• PRISMA 2020 explanation and elaboration: updated guidance and exemplars for reporting systematic reviews

  BMJ · 2021 · https://doi.org/10.1136/bmj.n160

• The PRISMA 2020 statement: An updated guideline for reporting systematic reviews

  International Journal of Surgery · 2021 · https://doi.org/10.1016/j.ijsu.2021.105906

• The PRISMA 2020 statement: an updated guideline for reporting systematic reviews

  Systematic Reviews · 2021 · https://doi.org/10.1186/s13643-021-01626-4

• Declaración PRISMA 2020: una guía actualizada para la publicación de revisiones sistemáticas

  Revista Española de Cardiología · 2021 · 10.1016/j.recesp.2021.06.016

• 2021 American College of Rheumatology Guideline for the Treatment of Rheumatoid Arthritis

  Arthritis & Rheumatology · 2021 · https://doi.org/10.1002/art.41752

• Physical distancing, face masks, and eye protection to prevent person-to-person transmission of SARS-CoV-2 and COVID-19: a systematic review and meta-analysis

  The Lancet · 2020 · 10.1016/s0140-6736(20)31142-9

• GRADE guidelines 26: informative statements to communicate the findings of systematic reviews of interventions

  Journal of Clinical Epidemiology · 2019 · 10.1016/j.jclinepi.2019.10.014

• PRISMA Extension for Scoping Reviews (PRISMA-ScR): Checklist and Explanation

  Annals of Internal Medicine · 2018 · 10.7326/m18-0850

• Guideline for opioid therapy and chronic noncancer pain

  Canadian Medical Association Journal · 2017 · 10.1503/cmaj.170363

• GRADE Evidence to Decision (EtD) frameworks: a systematic and transparent approach to making well informed healthcare choices. 1: Introduction

  BMJ · 2016 · 10.1136/bmj.i2016

• GRADE Evidence to Decision (EtD) frameworks: a systematic and transparent approach to making well informed healthcare choices. 2: Clinical practice guidelines

  BMJ · 2016 · 10.1136/bmj.i2089

• Antithrombotic Therapy for VTE Disease

  CHEST Journal · 2016 · 10.1016/j.chest.2015.11.026

• 2015 American College of Rheumatology Guideline for the Treatment of Rheumatoid Arthritis

  Arthritis & Rheumatology · 2015 · 10.1002/art.39480

• GRADE guidelines: 14. Going from evidence to recommendations: the significance and presentation of recommendations

  Journal of Clinical Epidemiology · 2013 · 10.1016/j.jclinepi.2012.03.013

• GRADE guidelines: 13. Preparing Summary of Findings tables and evidence profiles—continuous outcomes

  Journal of Clinical Epidemiology · 2012 · 10.1016/j.jclinepi.2012.08.001

• GRADE guidelines: 11. Making an overall rating of confidence in effect estimates for a single outcome and for all outcomes

  Journal of Clinical Epidemiology · 2012 · 10.1016/j.jclinepi.2012.01.006

• Prevention of VTE in Nonsurgical Patients

  CHEST Journal · 2012 · 10.1378/chest.11-2296

• Antithrombotic Therapy for VTE Disease

  CHEST Journal · 2012 · 10.1378/chest.11-2301

• GRADE guidelines: 1. Introduction—GRADE evidence profiles and summary of findings tables

  Journal of Clinical Epidemiology · 2011 · 10.1016/j.jclinepi.2010.04.026

• GRADE guidelines: 7. Rating the quality of evidence—inconsistency

  Journal of Clinical Epidemiology · 2011 · 10.1016/j.jclinepi.2011.03.017

• GRADE guidelines: 8. Rating the quality of evidence—indirectness

  Journal of Clinical Epidemiology · 2011 · 10.1016/j.jclinepi.2011.04.014

• GRADE guidelines: 5. Rating the quality of evidence—publication bias

  Journal of Clinical Epidemiology · 2011 · 10.1016/j.jclinepi.2011.01.011

• GRADE guidelines: 9. Rating up the quality of evidence

  Journal of Clinical Epidemiology · 2011 · 10.1016/j.jclinepi.2011.06.004

• GRADE guidelines: 4. Rating the quality of evidence—study limitations (risk of bias)

  Journal of Clinical Epidemiology · 2011 · 10.1016/j.jclinepi.2010.07.017

Current projects

No projects listed.